This pharmaceutical company’s recent drug developments could spell more gains ahead, according to Jefferies.
Recent Posts
- Data centers powering artificial intelligence could use more electricity than entire cities
- Donald Trump chooses hedge fund executive Scott Bessent for Treasury secretary
- Top 10 S&P 500 stock winners since Election Day
- Student loan legal battles delay SAVE borrowers’ path to forgiveness
- With the student loan repayment plan tied up in legal battles, millions of borrowers have had their monthly payments put on hold